Work

Phase I trial of siplizumab in CD2-positive lymphoproliferative disease

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.2533

Authors: J. E. Janik, J. C. Morris, M. Stetler-Stevenson, W. W. Gao, D. O’Hagan, L. S. Moses, M. Taylor, C. McEwen, L. D. Hammershaimb, T. A. Waldmann

Institution: National Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2244223549

Cites:

Cited by: 10

Related to: 10